Beta-blocker management in high-risk patients presenting for non-cardiac surgery: before and after the POISE trial

Kate Leslie, Paul S Myles, Richard Halliwell, Michael Paech, Timothy G Short, Stuart Walker

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

The POISE Trial was a randomised, placebo-controlled, double-blind study of the effectiveness of perioperative beta-blockade in preventing cardiac events including death in 8351 patients. Our hypothesis was that knowledge of the results of the POISE Trial would either increase or decrease the use of effective perioperative beta-blockade, depending on the result. Patients presenting for non-cardiac surgery and at risk of perioperative cardiac events were recruited in two cohorts before and after the release of the POISE Trial results. Effective perioperative beta-blockade was defined as heart rate
Original languageEnglish
Pages (from-to)319 - 327
Number of pages9
JournalAnaesthesia and Intensive Care
Volume40
Issue number2
Publication statusPublished - 2012

Cite this